Nihal Ahmad Selected Research

Sirtuins

1/2021	Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma.
1/2020	The sirtuin 6: An overture in skin cancer.
1/2020	Combined Inhibition of Specific Sirtuins as a Potential Strategy to Inhibit Melanoma Growth.
1/2020	Mitochondrial Sirtuins in Skin and Skin Cancers.
1/2018	RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis.
9/2017	SIRT6 histone deacetylase functions as a potential oncogene in human melanoma.
3/2017	Expression profile of SIRT2 in human melanoma and implications for sirtuin-based chemotherapy.
1/2017	Sirtuins in Skin and Skin Cancers.
4/2016	Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma.
1/2016	Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nihal Ahmad Research Topics

Disease

88	Neoplasms (Cancer) 04/2024 - 02/2002
37	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 01/2003
30	Melanoma (Melanoma, Malignant) 04/2024 - 04/2005
19	Carcinogenesis 01/2021 - 07/2003
16	Skin Neoplasms (Skin Cancer) 01/2020 - 04/2002
8	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2003
7	Adenocarcinoma 08/2020 - 01/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 08/2003
4	Carcinoma (Carcinomatosis) 05/2006 - 07/2003
3	Inflammation (Inflammations) 03/2021 - 02/2003
3	Skin Diseases (Skin Disease) 01/2020 - 09/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 05/2007
3	Edema (Dropsy) 07/2007 - 01/2003
2	Body Weight (Weight, Body) 01/2022 - 01/2017
2	Acute-Phase Reaction 01/2022 - 10/2019
2	Nevus (Nevi) 03/2017 - 01/2017
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014 - 04/2011
2	Hyperplasia 07/2007 - 07/2004
2	Prostatic Diseases 02/2004 - 01/2003

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2003
17	Polo-Like Kinase 1IBA 01/2024 - 04/2005
17	ResveratrolIBA 03/2021 - 01/2003
15	Phosphotransferases (Kinase)IBA 01/2024 - 01/2004
15	SirtuinsIBA 01/2021 - 02/2009
15	TeaIBA 07/2009 - 02/2002
13	Sirtuin 1IBA 01/2022 - 02/2009
12	AntioxidantsIBA 08/2020 - 04/2002
10	Small Interfering RNA (siRNA)IBA 01/2024 - 04/2005
9	AndrogensIBA 08/2020 - 02/2004
9	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2010 - 02/2002
8	Messenger RNA (mRNA)IBA 10/2022 - 01/2005
8	Histone Deacetylases (Histone Deacetylase)IBA 09/2017 - 02/2009
8	PolyphenolsIBA 03/2009 - 02/2002
6	Therapeutic UsesIBA 07/2013 - 04/2004
5	BI 6727IBA 02/2022 - 11/2014
5	Sirtuin 3IBA 01/2022 - 04/2016
5	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 11/2014
5	CyclinsIBA 04/2016 - 07/2004
5	sanguinarineIBA 04/2015 - 08/2003
5	MelatoninIBA 03/2011 - 10/2006
5	Hormones (Hormone)IBA 01/2011 - 10/2006
5	Guanosine Triphosphate (GTP)IBA 03/2009 - 01/2003
5	NF-kappa B (NF-kB)IBA 04/2004 - 01/2003
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 04/2002
4	PhytochemicalsIBA 05/2021 - 03/2009
4	Transcription Factors (Transcription Factor)IBA 08/2020 - 01/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2020 - 04/2005
4	enzalutamideIBA 01/2019 - 01/2016
4	Sunscreening Agents (Sunscreens)IBA 01/2019 - 04/2002
4	EnzymesIBA 01/2018 - 01/2003
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2024 - 06/2010
3	BI 2536IBA 02/2022 - 01/2015
3	ZincIBA 05/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2005
3	PowdersIBA 07/2020 - 01/2019
3	NAD (NADH)IBA 01/2017 - 03/2011
3	tenovin-1IBA 12/2014 - 01/2014
3	SeleniumIBA 06/2014 - 11/2008
3	Vitamin E FDA LinkGeneric 06/2014 - 11/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2009 - 02/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006 - 01/2003
3	SurvivinIBA 07/2005 - 11/2004
2	AntigensIBA 04/2024 - 09/2017
2	Cadherins (E-Cadherin)IBA 01/2024 - 01/2005
2	5- (2- (4- bromophenyl)vinyl)- 1,3- benzenediolIBA 01/2022 - 10/2019
2	CytokinesIBA 01/2022 - 07/2009
2	QuercetinIBA 08/2020 - 01/2016
2	Caspase 3 (Caspase-3)IBA 10/2019 - 01/2017
2	Cyclin D1IBA 10/2019 - 04/2005
2	Melanins (Melanin)IBA 01/2019 - 03/2017
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019 - 01/2014
2	Sirtuin 2IBA 01/2018 - 03/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	beta-Galactosidase (Lactaid)IBA 09/2017 - 04/2016
2	liquid crystal polymerIBA 09/2017 - 01/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2016 - 08/2004
2	CarcinogensIBA 01/2016 - 01/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 12/2015 - 01/2015
2	TrypsinIBA 04/2015 - 04/2014
2	AlkaloidsIBA 04/2015 - 05/2007
2	InterferonsIBA 07/2009 - 04/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 03/2009 - 12/2004
2	cytoplasmic antiproteinaseIBA 04/2006 - 01/2004
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2006 - 12/2004
2	Cyclin-Dependent Kinase 2IBA 04/2005 - 08/2004
2	AcetoneIBA 01/2005 - 01/2003
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2005 - 01/2003
2	Matrix Metalloproteinases (MMPs)IBA 12/2004 - 01/2003
1	CollagenIBA 04/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2022
1	erythromycin propionate-N-acetylcysteinateIBA 10/2022
1	Cell Cycle ProteinsIBA 10/2022

Therapy/Procedure

25	Chemoprevention 10/2019 - 02/2002
20	Therapeutics 04/2024 - 09/2004
7	Castration 01/2019 - 11/2014
5	Drug Therapy (Chemotherapy) 02/2022 - 05/2007
4	Immunotherapy 04/2024 - 03/2021
1	Photochemotherapy (Photodynamic Therapy) 04/2024